KATRINA CLARK: Open Payments
NPI 1376156364 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 16 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $32 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $157 |
| Neurocrine BioSciences, Inc. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lundbeck LLC | 2 | $33 |
| ABBVIE INC. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Corium, LLC | 1 | $6 |
Products named: INVEGA SUSTENNA, REXULTI, INGREZZA, CAPLYTA, VRAYLAR, Auvelity, COBENFY, Azstarys.
Industry payments across GA — which companies pay providers there.
